(Press-News.org) INDIANAPOLIS – Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help some patients.
With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain. The authors analyzed the opinions of 28 experts on the harms versus benefits of maintaining, tapering or terminating opioid pain medication prescriptions for chronic pain, a common condition worldwide that is typically quite difficult to treat.
The study authors found a lack of consensus among the experts on how to treat chronic (lasting three or more months) non-cancer pain. Slightly more than a third of the experts (36 percent) believed that long-term opioid therapy is beneficial, while an equal percentage indicated that it should be discontinued.
More than half of the experts believed that patients can experience harm from overly rapid tapering and discontinuation, while some recommended attempting a slow taper (even with a prior unsuccessful taper), possibly with addition of medications to manage withdrawal) in order not to maintain opioid therapy.
Some of the experts advocated for switching patients to buprenorphine, which diminishes the effects of physical dependency to opioids, such as withdrawal symptoms and cravings, and is used to treat pain. Some considered adding non-opioid pain therapies (including re-trying these therapies even if they were unhelpful in the past) as well as engaging in shared decision-making with the patient, although there was little consensus on how to accomplish these options.
Some, but not all of the experts, noted the benefit of addressing co-occurring conditions related to patient safety, such as alcohol use, mental health symptoms and opioid side effects.
Few of the experts brought up assessing or addressing opioid use disorder or overdose risk.
“The potential harms of opioid pain medication are well known, nevertheless patients can become habituated to them and want their physicians to continue prescribing them. Taking patients off opiates may result in return or worsening of chronic pain, mental health issues, drug seeking and potentially overdose and death. Additionally, these drugs could be used by someone else, possibly winding up on the street,” said study co-author Kurt Kroenke, M.D. of the Regenstrief Institute and the Indiana University School of Medicine. “On the benefit side, these drugs may be helping relieve the patient’s often debilitating pain which can impact the ability to interact with family, to hold a job, participate in social activities and many other aspects of life.”
A substantial number of people who are prescribed opioid pain medications continue to experience chronic pain. Dr. Kroenke notes that these individuals may be good candidates for tapering to a lower dose, prescription discontinuation and moving on to effective, safer treatments for pain.
The authors conclude their analysis of the experts’ opinions, “Guidelines on whether to continue or taper opioids prescribed long- term may be difficult to utilize given professional liability concerns, changing regulations and health system initiatives, differing provider-patient perspectives on long-term opioid benefits and harms, and some providers' beliefs that opioid dependence interferes with patients' objectivity. In the meantime, individual care decisions that involve weighing relative harms should draw on longstanding norms of ethical medical care that call for informed consent and patient-provider conversations grounded in mutual respect.”
“Management of patients at risk of harms from both continuing and discontinuing their long- term opioid therapy: A qualitative study to inform the gap in clinical practice guidelines” is published in the peer-reviewed journal Pain Practice.
Authors and affiliations as listed in the publication:
Christine Timko1,2, Mai Chee Lor1, Stefan Kertesz3,4, Kurt Kroenke5, Kathryn Macia1, Andrea Nevedal6, Katherine J Hoggatt7,8.
1Center for Innovation to Implementation, Department of Veterans Affairs Health Care System, Palo Alto, California, USA.
2Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.
3Birmingham VA Health Care System, Birmingham, Alabama, USA.
4Heersink UAB School of Medicine, Birmingham, Alabama, USA.
5Regenstrief Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
6Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
7San Francisco VA Health Care System, San Francisco, California, USA.
8Department of Medicine, University of California, San Francisco, California, USA.
This research was supported by the U.S. Department of Veterans Affairs (HSR IIR 18–253 to Dr. Timko and Dr. Hoggatt; RCS 00–001 to Dr. Timko).
Kurt Kroenke, M.D.
In addition to his role as a research scientist with the William M. Tierney Center for Health Services Research at Regenstrief Institute, Kurt Kroenke, M.D., is an Indiana University Indianapolis Chancellor’s Professor and a professor of medicine at the Indiana University School of Medicine.
END
Both sides of the coin: Lack of consensus on continuing vs. discontinuing opioid medications prescriptions for adults with chronic pain
2025-02-20
ELSE PRESS RELEASES FROM THIS DATE:
National Academy of Inventors welcomes 162 emerging inventors
2025-02-20
The National Academy of Inventors (NAI) has announced the 2025 class of Senior Members, comprised of 162 emerging inventors from NAI’s Member Institutions. This year’s class of NAI Senior Members is the largest to date and hails from 64 NAI Member Institutions across the nation. Collectively, they are named inventors on over 1200 U.S. patents.
“To see this program grow year over year is a testament to the dedication our Member Institutions have to fostering innovation on their campuses and supporting their inventive staff ...
Narcissists more likely to feel ostracized
2025-02-20
Narcissists feel ostracized more frequently than their less self-absorbed peers, according to research published by the American Psychological Association. This may stem not only from being shunned due to their personalities but from a tendency to misinterpret ambiguous social signals as exclusion.
“Feeling ostracized is a subjective experience based on the perception of social cues by the individual. Some may be intentionally ostracized, while others may merely believe they are being excluded when that’s not the case,” said lead author Christiane Büttner, PhD, of the University of Basel. “Our findings suggest that ...
Unfolded protein response: A key regulator of intestinal health and disease
2025-02-20
The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and communication between the gut microbiota and the nervous system. To maintain homeostasis, intestinal epithelial cells (IECs) must efficiently manage protein production and secretion, a process tightly controlled by the unfolded protein response (UPR).
New research published in eGastroenterology demonstrates that disruptions in the UPR contribute to inflammatory bowel diseases (IBD), colorectal cancer, and other gut-related disorders. This highlights potential therapeutic strategies to restore ...
Small amounts of moderate to vigorous physical activity are associated with big reductions in dementia risk
2025-02-20
A little movement could help prevent dementia, even for frail older adults, suggests a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
The researchers found that engaging in as little as 35 minutes of moderate to vigorous physical activity per week, compared to zero minutes per week, was associated with a 41% lower risk of developing dementia over an average four-year follow-up period. Even for frail older adults—those at elevated risk of adverse health outcomes—greater activity was associated with lower dementia risks.
The ...
Enhancing adhesive performance of polyvinyl alcohol with sub-nanoscale polyoxotungstate clusters under extreme conditions
2025-02-20
Water-based adhesives face several challenges despite their environmental benefits. One major issue is that achieving high adhesion strength on various substrates, especially in wet or humid conditions, is difficult due to the inherent properties of water-based systems. Additionally, the volatility of water also leads to issues like bubble formation and uneven drying, affecting the adhesive's performance and appearance. Moreover, formulating water-based adhesives with both high solids content and low viscosity is technically demanding, ...
Recognizing the evolution of clinical syndrome spectrum progression in individuals with single large-scale mitochondrial DNA deletion syndromes (SLSMDS))
2025-02-20
Philadelphia, February 20, 2025 – Researchers from the Mitochondrial Medicine Program at Children’s Hospital of Philadelphia (CHOP) have better characterized a spectrum of what were classically considered discrete mitochondrial DNA deletion disease syndromes. The findings offer new insights into genetic causes, potential symptoms, and disease progression, and may inform future clinical trial development. The findings were published today in the journal Genetics in Medicine.
Mitochondrial disease refers to a group of disorders that affect the mitochondria, which are tiny compartments present in almost every cell of the body that ...
Another way longer paternity leaves help new parents
2025-02-20
A longer paternity leave after the birth of a child can improve the co-parenting relationship between moms and dads in a key way, a new study finds.
Researchers found that mothers were less likely to discourage fathers’ involvement in parenting if the dads had taken more time off after their child was born.
“When fathers take longer leaves, mothers might take that as a sign that fathers are more interested in being an active parent and be less likely to try to prevent them from participating in child care,” said Reed Donithen, ...
Johnson & Johnson MedTech celebrates inaugural National Heart Recovery Awareness Day
2025-02-20
DANVERS, Mass., February 20, 2025 – Johnson & Johnson MedTech, the global leader in heart recovery, is proud to celebrate the inaugural National Heart Recovery Awareness Day today, February 20. Recognized through a U.S. Congressional resolution, this designation will help increase awareness of heart health and how innovative medical technology helps patients return home to their families – with their native heart. There are events taking place across the country where patients are sharing their stories, including heart recovery reunions and sessions to educate healthcare providers, which underscore the impact that heart recovery has ...
Novel inhalable gene therapy trialled for people with cystic fibrosis
2025-02-20
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
Cystic fibrosis (CF) is caused by defects in the CFTR gene, which causes a buildup of thick sticky mucus in the lungs and digestive system. It causes lung infections and gradually affects the ability to breathe. The new lentiviral vector-based gene therapy works by inserting a functioning copy of the CFTR gene in the DNA of the epithelial cells in a patient’s airway.
At ...
Plasma arc cutting: PNU and KIMM scientists together decode gas flow dynamics
2025-02-20
Plasma arc cutting (PAC) is a thermal cutting technique widely used in manufacturing applications such as shipbuilding, aerospace, fabrication, nuclear plants decommissioning, construction industry, and the automotive industry. In this process, a jet of plasma or ionized gas is ejected at high speeds, which melts and subsequently removes unwanted parts of materials from electrically conductive workpieces such as metals. The plasma jet is typically produced in two steps: pressuring a gas through a small nozzle hole and generating an electric arc via power supply. Remarkably, the introduced arc ionizes ...